Sutent Den europeiske union - portugisisk - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

BONAR Brasil - portugisisk - ANVISA (Agência Nacional de Vigilância Sanitária)

bonar

achÉ laboratÓrios farmacÊuticos s.a - sulfato de bleomicina - antibioticos antineoplasicos

EVOFLUBINA Brasil - portugisisk - ANVISA (Agência Nacional de Vigilância Sanitária)

evoflubina

farmarin industria e comercio ltda - fosfato de fludarabina - antineoplasico

FLUDALIBBS Brasil - portugisisk - ANVISA (Agência Nacional de Vigilância Sanitária)

fludalibbs

libbs farmacÊutica ltda - fosfato de fludarabina - antimetabolicos analogos da purina

RUXIENCE Brasil - portugisisk - ANVISA (Agência Nacional de Vigilância Sanitária)

ruxience

pfizer brasil ltda - rituximabe - antineoplasicos citotoxicos